Organon & Co. Annual Deferred Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Organon & Co. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Organon & Co. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $5M, a 66.7% increase year-over-year.
  • Organon & Co. annual Deferred Income Tax Expense (Benefit) for 2023 was -$485M, a 2594% decline from 2022.
  • Organon & Co. annual Deferred Income Tax Expense (Benefit) for 2022 was -$18M, a 93.8% increase from 2021.
  • Organon & Co. annual Deferred Income Tax Expense (Benefit) for 2021 was -$288M, a 800% decline from 2020.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$485M -$467M -2594% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 -$18M +$270M +93.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 -$288M -$256M -800% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$32M -$44M -367% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $12M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.